Drugmaker Eli Lilly & Co announced that the FDA has issued a complete response letter, meaning it has not granted accelerated approval for amyloid-clearing...
Ardelyx, Inc., a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, announced...
Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced that the company received...
Overhearing.com announced immediate availability of over-the-counter hearing aids, enabling Americans to alleviate mild to moderate hearing loss without the need for a prescription.
"These new...
Alexis Bio, a private regenerative medicine company, announced that realSKIN™ is the first live cell xenotransplant product to be designated as a Regenerative Medicine...
